Brief: Mabion Signs New Deal With Brazil's IBMP For Drug Manufacturing Technology Transfer
18/08/2025 15:25
Aug 18 (Reuters) - Mabion SA MABP.WA: SIGNS ANOTHER DEAL WITH IBMP UNDER SOW#2 FRAMEWORK DEAL NET REMUNERATION FOR PROJECT MANAGEMENT IS APPROX. 1.6 MILLION PLN SOW#2 INVOLVES TECHNOLOGY TRANSFER FOR DRUG MANUFACTURING Source text: ID:nEM2jBBzza Further company coverage: MABP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Mabion SA
See all newsBrief: Mabion Signs Annex To Extend Production Agreement With Novavax To End of 2029
Brief: Mabion Signs Deal With Oddifact Sas On Preparing Mabioncd20 For FDA Consultation
Brief: Mabion Q1 Net Loss 9.7 Million Zlotys
Brief: Mabion Signs LoI With Oddifact On Use Of MabionCD20 Drug For Orphan Diseases
Brief: Mabion FY Net Loss 62.6 Million Zlotys